Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery

NCT05898334 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2024-07-01

No results posted yet for this study

Summary

The purpose of this clinical research is to verify if the patients with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. The main study questions are:

* Can patients with chronic stroke regain life independence by normalizing Activities of Daily Living (ADL).
* Can brain-injury and recovery status of the patients with chronic stroke be detected by using an EEG machine.

Participants will sleep-rest on a hotel bed energized by Tesla BioHealing Biophoton Generators, and clinical study staff will observe the participant's activities of daily living, as compared to those who will sleep in the hotel room equipped with placebo devices.

Conditions

  • Chronic Stroke
  • Paralysis

Interventions

DEVICE

Active Biophoton Generators

The whole body, including brain, of the study participant will be sleeping inside of the strong biophoton field so her/his entire body will be energized to promote self-healing.

DEVICE

Inactive Biophoton Generators

The whole body, including brain, of the study participant will be sleeping inside of the normal hotel bed and the participant will not receive any biophotons.

Sponsors & Collaborators

  • First Institute of All Medicines

    lead OTHER

Principal Investigators

  • Mariola Smotrys, MD, MBA, MSc · First Institute of All Medicines

  • James Z Liu, MD, PhD · First Institute of All Medicines

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-10
Primary Completion
2024-06-28
Completion
2024-06-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05898334 on ClinicalTrials.gov